XML 41 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Exchange Agreement with Immunic AG - Additional Information (Details)
€ in Millions, $ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
Mar. 31, 2019
EUR (€)
Jan. 31, 2019
Vital Therapies, Inc. | Immunic, Inc.      
Class of Stock [Line Items]      
Expected ownership percentage     89.00%
Reverse Merger Investment      
Class of Stock [Line Items]      
Consideration received on transaction $ 30.0 € 26.7